Nanoparticles in Modern Medical Technology

Julia Merlin^*
*Correspondence: Julia Merlin, Department of Nanoscience, Pharmaceutical and Nanotech Research Centre, Houston, Texas, USA, Email:

Introduction

There are many advantages of nanoparticles for contemporary medicine. In fact, there are some situations where using nanoparticles makes it possible to perform studies and treatments that would otherwise be impossible. However, because of their toxicity in particular, nanoparticles pose special environmental and socioeconomic problems. This review will explore the societal and environmental implications of nanoparticle use as well as the significant contributions that nanoparticles have made to modern medicine.

Description

There are several intriguing potential for the application of nanotechnology in medicine. Some techniques are still simply ideas, while others are being tested or are already in use. Applications of currently being developed nanoparticles as well as longer-range research involving the employment of produced nano-robots to perform cellular repairs are both possible with the help of nanotechnology in medicine.

The life sciences sector is experiencing fresh growth thanks to the application of nanotechnology in healthcare. Nanotechnology has the enormous potential to change a wide range of medical care practises, including diagnosis, illness monitoring, surgical instruments, regenerative medicine, vaccine development, and medication delivery. Through the use of cutting-edge research methods that can be employed for drug discovery, it is also opening doors to better treatment alternatives for a variety of ailments.

There are hardly any restrictions on the field's possible applications because it deals with matter at the atomic and molecular level. The development and improvement of microscopes are equivalent to the ability to alter matter at this scale in medical science. It has the potential to revolutionise drug delivery, wound care, gene therapy, diagnostics, and nearly every area of medicine in the future. As nanomedicine is still in its infancy, it's fascinating for us to have the chance to be at the forefront and experience this revolution. That said, it already has a huge impact, and it’s going to play an increasingly important role in the coming years. Newly developed nanosensors can be used to detect harmful environmental pollutants, such as chromium. As a result, it is anticipated that these new technologies will usher in a period of enhanced healthcare in terms of prevention, diagnosis, and treatment.

The use of contrast chemicals is necessary in many therapeutic applications since the natural differences in relaxation times across regions of interest (such as normal vs scar tissue) are negligible. Contrast agents are usually paramagnetic compounds that can change the relaxation times of particular bodily fluids, tissues, or areas. Gadolinium compounds have been successfully used as contrast agents for years, allowing for the resolution of various body parts, including the kidney and the brain. Contrast drugs made of gadolinium function by reducing T1. Recently, efficient contrast agents for T2-weighting using superparamagnetic iron oxide (SPIO) nanoparticles have been available, complementing gadolinium-based agents. For imaging of the liver, lymph nodes, and bone, T2 weighting is crucial [1-5].

Conclusion

The difficulty of delivering precisely focused interventions has been one of the main obstacles to achieving this. For the majority of medical history, administering pharmaceuticals that have a variety of effects on the body or the brain, some of which are desired, has been the most effective way to treat various disorders. We must carefully assess any collateral harm or side effects that may result from this procedure. Evidently, drugs with more advantages than hazards are more likely to be approved. However, employing nanoparticles, direct involvement at the cellular level is now possible thanks to nanotechnology.

References

1. Murthy, Shashi K. "Nanoparticles in modern medicine: State of the art and future challenges." Int J Nanomed 2 (2007): 129.

Indexed at, Google Scholar

2. Manzano, Miguel and María Vallet-Regí. "Mesoporous silica nanoparticles for drug delivery." Adv Funct Mater 30 (2020): 1902634.

Indexed at, Google Scholar, Crossref

3. Banik, Brittany L., Pouria Fattahi and Justin L. Brown. "Polymeric nanoparticles: The future of nanomedicine."  Nanomed Nanobiotechnol 8 (2016): 271-299.

Indexed at, Google Scholar, Crossref

4. Sindhwani, Shrey and Warren CW Chan. "Nanotechnology for modern medicine: next step towards clinical translation." J Int Med 290 (2021): 486-498.

Indexed at, Google Scholar, Crossref

5. Hsu, Jessica C, Lenitza M. Nieves, Oshra Betzer and Tamar Sadan, et al. "Nanoparticle contrast agents for Xâ?ray imaging applications." Nanomed Nanobiotechnol 12 (2020): e1642.

Indexed at, Google Scholar, Crossref